New Drugs

Brand/Generic Company Description
Albrioza
sodium phenylbutyrate/ursodoxicoltaurine
Amylyx/Innomar Strategies

An oral combination that may reduce neuronal death in patients with amyotrophic lateral sclerosis (ALS).

Bimzelx
bimekizumab
UCB Canada

A monoclonal antibody for moderate to severe plaque psoriasis.

Breyanzi
lisocabtagene maraleucel
Celegene

An immunotherapy for B-cell lymphoma.

Byooviz
ranibizumab
Biogen Canada

A biosimilar to Lucentis.

Cibinqo
abrocitinib
Pfizer Canada

A Janus kinase-1 inhibitor for refractory, moderate to severe atopic dermatitis.

Covifenz
COVID-19 vaccine
Medicago

A plant-based, recombinant, adjuvanted vaccine for prevention of COVID-19.

Evusheld
tixagevimab and cilgavimab
AstraZeneca Canada

A combination monoclonal antibody for pre-exposure prophylaxis of COVID-19.

HyQvia
immunoglobulin/ hyaluronidase
Takeda

A subcutaneous replacement therapy for immunodeficiencies.

Letybo
letibotulinumtoxinA
Croma Aesthetics

A neuromuscular blocking agent to temporarily improve moderate to severe frown lines between the eyebrows.

Nuvaxovid
COVID-19 vaccine
Novavax (US)/ Innomar Strategies

Adjuvanted vaccine for prevention of COVID-19.

Ontruzant
trastuzumab
Samsung Bioepsis/ Organon

A biosimilar to Herceptin.

Orladeyo
berotralstat
BioCryst/Innomar Strategies

An oral plasma kallikrein inhibitor to prevent hereditary angioedema.

Oxlumo
lumasiran
Alnylam Netherlands/ Innomar Strategies

A glycolate oxidase reducer for primary hyperoxaluria.

Palynziq
pegvaliase
Biomarin

An enzyme that reduces blood phenylalanine concentrations in phenylketonuria.

Paxlovid
nirmatrelvir/ritonavir
Pfizer Canada

New oral antiviral for mild to moderate COVID-19 infection in patients at high risk for progression to severe COVID-19.

Poteligeo
mogamulizumab
Kyow Kirin/Innomar Strategies

A monoclonal antibody for mycosis fungoides or Sezary syndrome.

Prevnar 20
pneumococcal vaccine
Pfizer Canada

20-valent vaccine for prevention of pneumococcal disease.

Rholistiq
belumosudil
Kadmon (US)

A protein kinase inhibitor for chronic graft-versus-host disease.

Rybrevant
amivantamab
Janssen

A new monoclonal antibody for locally advanced/metastatic non-small cell lung cancer.

Scemblix
asciminib
Novartis

A tyrosine kinase inhibitor for chronic phase chronic myeloid leukemia.

Semglee
insulin glargine
BGP Pharma/Viatris

A biosimilar to Lantus.

Simlandi
adalimumab
Jamp Pharma

A biosimilar to Humira.

Slynd
drospirenone
Duchesnay

New progestin-only oral contraceptive.

Sohonos
palovarotene
Ipsen

An oral retinoic-acid receptor gamma agonist for fibrodysplasia ossificans progressiva.

Tabrecta
capmatinib
Novartis

New oral protein kinase inhibitor for non-small cell lung cancer.

Tavneos
avacopan
Otsuka Canada

New oral complement 5a antagonist for active anti-neutrophil cytoplasmic auto-antibody associated vasculitis.

Tezspire
tezepelumab
AstraZeneca Canada

A new monoclonal antibody for severe asthma.

Vraylar
cariprazine
Allergan

New oral atypical antipsychotic for schizophrenia and bipolar I disorder.

Welireg
belzutifan
Merck

An oral hypoxia-inducible factor 2 alpha (HIF-2α) inhibitor for von Hippel-Lindau disease-associated renal cell carcinoma.

Xpovio
selinexor
Forus Therapeutics

An oral inhibitor of tumor suppressor proteins for multiple myeloma.

Brand/Generic Company Description
Benvyon
bendamustine
Pfizer

A new solution formulation.

Duokopt
dorzolamide/timolol
Thea Lab

A preservative-free formulation.

Esamuze
bendamustine
Dr. Reddy’s

A concentrated bendamustine solution (requires dilution before IV infusion).

Lumify
brimonidine
Bausch Health

A lower strength, over-the-counter ophthalmic solution.

Zynrelef
bupivacaine/meloxicam
Heron Therapeutics (US)

A combination analgesic solution for surgical wound instillation.

Brand/Generic Company Description